Single-dose new insulin glargine 300 U/ml provides prolonged, stable glycaemic control in Japanese and European people with type 1 diabetes

AIMS: Two single-dose studies were conducted in Japan and Europe to compare the pharmacokinetic (PK) and pharmacodynamic (PD) profiles of new insulin glargine 300 U/ml (Gla-300) and insulin glargine 100 U/ml (Gla-100) in people with type 1 diabetes mellitus. METHODS: In two double-blind, randomized,...

Descripción completa

Detalles Bibliográficos
Autores principales: Shiramoto, M, Eto, T, Irie, S, Fukuzaki, A, Teichert, L, Tillner, J, Takahashi, Y, Koyama, M, Dahmen, R, Heise, T, Becker, R H A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342764/
https://www.ncbi.nlm.nih.gov/pubmed/25425297
http://dx.doi.org/10.1111/dom.12415

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342764/
https://www.ncbi.nlm.nih.gov/pubmed/25425297
http://dx.doi.org/10.1111/dom.12415

Ejemplares similares